Integration of local and systemic immunotherapy: setting new standards in liver-confined hepatocellular carcinoma

Key Points

• Integration of local and systemic immunotherapy enhances treatment outcomes in hepatocellular carcinoma.
• A significant increase in immune response was observed with combined immunotherapy approaches.
• Observational analysis of hepatic tumor responses demonstrated effectiveness over monotherapy.
• This approach highlights the need for novel treatment strategies to improve patient outcomes.